Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
|
US |
|
Scanfil Oyj
LSE:0Q59
|
FI |
|
Land & Homes Group Ltd
ASX:LHM
|
AU |
|
TechTarget Inc
NASDAQ:TTGT
|
US |
|
Nexus Surgical and Medicare Ltd
BSE:538874
|
IN |
|
Tadano Ltd
TSE:6395
|
JP |
|
T
|
Tamil Nadu Steel Tubes Ltd
BSE:513540
|
IN |
|
F
|
Fairfax Financial Holdings Ltd
OTC:FRFHF
|
CA |
|
Reliable Data Services Ltd
NSE:RELIABLE
|
IN |
|
P
|
PSI Software AG
OTC:PSSWF
|
DE |
|
H
|
H-One Co Ltd
TSE:5989
|
JP |
|
Shinkong Textile Co Ltd
TWSE:1419
|
TW |
|
Destinasi Tirta Nusantara Tbk PT
IDX:PDES
|
ID |
|
Histogen Inc
OTC:HSTOQ
|
US |
|
Glaukos Corp
NYSE:GKOS
|
US |
|
P
|
Posiflex Technology Inc
TWSE:8114
|
TW |
|
Matinas BioPharma Holdings Inc
F:6LJ
|
US |
|
B
|
Brazilian Electric Power Co
SWB:L3X
|
BR |
|
Soluciones Cuatroochenta SA
F:5XW
|
ES |
|
H
|
Hong Kong ChaoShang Group Ltd
HKEX:2322
|
HK |
|
Lenta Plc
LSE:LNTA
|
RU |
|
Kilroy Realty Corp
NYSE:KRC
|
US |
|
ENC Digital Technology Co Ltd
SSE:603869
|
CN |
|
T
|
Tbo Tek Ltd
NSE:TBOTEK
|
IN |
Multiples-Based Value
The
Multiples-Based Value for
Tonix Pharmaceuticals Holding Corp (TNXP)
under the Base Case is
hidden
USD.
Compared with the current market price of 14.01 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
TNXP Competitors Multiples
Tonix Pharmaceuticals Holding Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
|
183.4m USD | 13.7 | -1.4 | 0.2 | 0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
368.5B USD | 6 | 88.3 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.7B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD | 9.3 | 28.4 | 21.3 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD | 5.5 | 17.6 | 13 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.9B EUR | 12.4 | 39.8 | 43.2 | 44.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD | 2.9 | 32.4 | 10.9 | 13.8 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |